Repurchase Agreements in the Biotechnology Industry
23 Contracts & Agreements
- AGENUS INC (1 contract)
- AGIOS PHARMACEUTICALS INC (1)
- Alliqua BioMedical, Inc. (1)
- Amgen Inc. (1)
- Anika Therapeutics (3)
- Arbutus Biopharma Corp (2)
- Axcella Health Inc. (1)
- CTI BIOPHARMA CORP (1)
- CYTORI THERAPEUTICS, INC. (1)
- Emerald Bioscience, Inc. (1)
- Inmune Bio, Inc. (1)
- Minerva Neurosciences, Inc. (1)
- Organogenesis Holdings Inc. (1)
- Regeneron Pharmaceuticals (1)
- Savara Inc (1)
- Synthetic Biologics, Inc. (1)
- United Therapeutics Corp (1)
- Viking Therapeutics, Inc. (2)
- Virios Therapeutics, LLC (1)
- Form of Stock Repurchase Agreement, dated November 12, 2024 (Organogenesis Holdings Inc., Filed With SEC on November 13, 2024)
- Form of Repurchase Agreement, dated October 7, 2024, by and between the Virios Therapeutics, Inc. and Sealbond limited (Virios Therapeutics, LLC, Filed With SEC on November 8, 2024)
- Master Confirmation Accelerated Share Repurchase, between the Company and Citi, dated March 25, 2024 (United Therapeutics Corp, Filed With SEC on March 25, 2024)
- Form of Share Repurchase Agreement between Theriva Biologics, Inc. and certain selling stockholders (Synthetic Biologics, Inc., Filed With SEC on December 23, 2022)
- Share Repurchase Agreement, dated as of March 31, 2021, by and between Agios Pharmaceuticals, Inc. and Bristol-Myers Squibb Company (AGIOS PHARMACEUTICALS INC, Filed With SEC on April 2, 2021)
- Form of Warrant Repurchase Agreement (Savara Inc, Filed With SEC on March 11, 2021)
- Stock Repurchase Agreement, dated as of May 25, 2020, by and between Regeneron Pharmaceuticals, Inc. and Sanofi (Regeneron Pharmaceuticals, Filed With SEC on May 29, 2020)
- Common Stock Repurchase Agreement (Inmune Bio, Inc., Filed With SEC on January 27, 2020)
- Fixed Dollar Accelerated Share Repurchase Transaction, dated May 7, 2019, by and between Anika Therapeutics, Inc. and Morgan Stanley & Co. LLC (Anika Therapeutics, Filed With SEC on July 26, 2019)
- Stock Repurchase Agreement between the Registrant and Robert Connelly, effective as of May 31, 2018 (Axcella Health Inc., Filed With SEC on April 12, 2019)
- Fixed Dollar Accelerated Share Repurchase Transaction Confirmation entered into as of May 24, 2018 by and between Morgan Stanley & Co. LLC and Anika Therapeutics, Inc (Anika Therapeutics, Filed With SEC on July 31, 2018)
- Fixed Dollar Accelerated Share Repurchase Transaction (Anika Therapeutics, Filed With SEC on May 3, 2016)
- SHARE REPURCHASE AGREEMENT (Arbutus Biopharma Corp, Filed With SEC on August 7, 2015)
- SHARE REPURCHASE AGREEMENT (Arbutus Biopharma Corp, Filed With SEC on August 7, 2015)
- AMENDED AND RESTATED STOCK REPURCHASE AGREEMENT (Viking Therapeutics, Inc., Filed With SEC on June 12, 2015)
- Share Repurchase and Cancellation Agreement between the Registrant, Yosbani Mendez and Francisco Mendez. dated October 31, 2014 (Emerald Bioscience, Inc., Filed With SEC on November 3, 2014)
- STOCK REPURCHASE AGREEMENT (Viking Therapeutics, Inc., Filed With SEC on September 8, 2014)
- STOCK REPURCHASE AGREEMENT (Minerva Neurosciences, Inc., Filed With SEC on April 9, 2014)
- ANTIGENICS INC. SECURITIES REPURCHASE AGREEMENT (AGENUS INC, Filed With SEC on March 16, 2011)
- WARRANT REPURCHASE AGREEMENT (Alliqua BioMedical, Inc., Filed With SEC on April 28, 2009)
- VARIABLE TERM ACCELERATED SHARE REPURCHASE TRANSACTION (Amgen Inc., Filed With SEC on August 8, 2008)
- WARRANT REPURCHASE AGREEMENT (CTI BIOPHARMA CORP, Filed With SEC on October 19, 2006)
- DescriptionOf December 8, 2003 Stock Repurchase Transaction With Insiders (CYTORI THERAPEUTICS, INC., Filed With SEC on March 31, 2005)
